Codon 311 (Cys→Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias

被引:44
作者
Janka, Z
Juhász, A
Rimanóczy, A
Boda, K
Márki-Zay, J
Kálmán, J
机构
[1] Univ Szeged, Fac Med, Dept Psychiat, Albert Szent Gyorgyi Ctr Med & Pharmaceut Sci, H-6725 Szeged, Hungary
[2] Bekes Cty Hosp, Cent Lab, H-5701 Gyula, Hungary
关键词
paraoxonase; apolipoprotein E; genetic markers; Alzheimer's disease; vascular dementia; DNA polymorphism;
D O I
10.1038/sj/mp/4000916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene of an esterase enzyme, called paraoxonase (PON, EC.3.1.8.1.) is a member of a multigene family that comprises three related genes PON1, PON2, and PON3 with structural homology clustering on the chromosome 7.(1,2) The POW activity and the polymorphism of the POW and PON2 genes have been found to be associated with risk of cardiovascular diseases such as hypercholesterolaemia, non-insulin-dependent diabetes, coronary heart disease (CHD) and myocardial infaction.(3-8) The importance of cardiovascular risk factors in the pathomechanism of Alzheimer's disease (AD) and vascular dementia (VD)(9-13) prompted us to examine the genetic effect of PON2 gene codon 311 (Cys-Ser; PON2*S) polymorphism and the relationship between the PON2*S allele and the other dementia risk factor, the apoE polymorphism in these dementias. The PON2*C and PON2*S allele frequencies were similar in both AD (25% and 75%) and VD groups (23% and 77%), respectively, compared with the controls (27% and 73%). The ratio of the PON2*S carriers was significantly higher among the apoE4 allele carrier AD (27%) and VD (25%) groups than in the control (12%). Our results indicate that the PON2*S and apoE4 alleles have interactive effect on the development of the two most common forms of dementias AD and VD, and further support the hypothesis that cardiovascular factors contribute to the development of AD.
引用
收藏
页码:110 / 112
页数:3
相关论文
共 25 条
[1]   SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]  
ANTAKAINEN M, 1996, J CLIN INVEST, V98, P883
[3]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[4]  
CSASZAR A, 1997, NEUROSCI LETT, V230, P1
[5]   Critical threshold cerebral hypoperfusion causes Alzheimer's disease? [J].
de la Torre, JC .
ACTA NEUROPATHOLOGICA, 1999, 98 (01) :1-8
[6]  
Garin M.C., 1997, J CLIN INVEST, V99, P62
[7]   Low blood pressure and dementia in elderly people: The Kungsholmen project [J].
Guo, ZC ;
Viitanen, M ;
Fratiglioni, L ;
Winblad, B .
BRITISH MEDICAL JOURNAL, 1996, 312 (7034) :805-808
[8]  
HALLMAN DM, 1991, AM J HUM GENET, V49, P338
[9]   CLASSIFICATION OF THE EUROPEAN LANGUAGE FAMILIES BY GENETIC-DISTANCE [J].
HARDING, RM ;
SOKAL, RR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :9370-9372
[10]   Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease [J].
Kálmán, J ;
Kudchodkar, BJ ;
Murray, K ;
McConathy, WJ ;
Juhász, A ;
Janka, Z ;
Lacko, AG .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (06) :488-493